文献速递关节外科

高手术量关节置换中心行初次全髋与全膝关节置换术的医院成本更低:基于2019年288909例Medicare索赔的数据库研究

High-volume Arthroplasty Centers Are Associated With Lower Hospital Costs When Performing Primary THA and TKA: A Database Study of 288,909 Medicare Claims for Procedures Performed in 2019.
PubMed 文献 · Clin Orthop Relat Res · 2022-11-07

本研究基于2019年Medicare索赔数据,分析288909例初次择期住院全髋和全膝关节置换术,发现医院手术量越高,调整患者特征后医院成本越低、住院时间越短、出院回家率越高。作者认为中小型区域医院受支付下降冲击更大,需进一步研究成本差异驱动因素。

要点

  • 年手术量≤10例、11–100例、101–200例的医院,其住院关节置换成本分别是年手术量≥201例医院的1.32倍、1.17倍、1.10倍(p<0.001)。
  • 低手术量医院患者住院超过2天的OR为1.25至3.44(95%CI 1.10至4.03;p<0.001),出院回家OR为0.34至0.78(95%CI 0.29至0.86;p<0.001)。
  • 作者认为中小型区域医院受支付下降冲击更大,需进一步研究以识别手术量相关成本差异的关键驱动因素。

核心结论

  • 高手术量医院行住院全髋和全膝关节置换术时,成本更低、住院时间更短、出院回家率更高。
  • 作者认为中小型区域医院受报销下降的冲击更大,在捆绑支付模式下可能需要特殊对待以维持运营。
  • 作者提出需进一步研究以识别手术量相关成本差异的关键驱动因素。

研究设计与样本

  • 数据来源为Medicare Provider Analysis and Review Limited Data Set,包含100%住院Medicare住院索赔数据。
  • 纳入2019年初次择期住院全髋和全膝关节置换术患者,排除非住院预付费系统住院、非择期入院、双侧手术及骨盆或下肢肿瘤患者。
  • 研究期间2762家医院共实施500658例关节置换术,覆盖492262名Medicare受益人;应用排除标准后分析288909例(59%)。
  • 大多数排除(37%,182733/492262)因非住院预付费系统住院。
  • 研究组中87%(251996/288909)为65至84岁患者,88%(255415/288909)为白人患者,63%(180688/288909)为女性患者。

主要发现

  • 医院成本与平均住院时间随医院手术量增加而降低,出院回家率随手术量增加而升高。
  • 控制患者人口学、健康状况和地理位置等混杂因素后,年手术量≤10例、11–100例、101–200例的医院住院关节置换成本分别是年手术量≥201例医院的1.32倍(95%CI 1.30至1.34;p<0.001)、1.17倍(95%CI 1.17至1.17;p<0.001)、1.10倍(95%CI 1.10至1.10;p<0.001)。
  • 在较小手术量医院治疗的患者住院超过2天的OR为1.25至3.44(95%CI 1.10至4.03;p<0.001),出院回家OR为0.34至0.78(95%CI 0.29至0.86;p<0.001)。

关键数值与推荐

  • 年手术量≤10例医院成本为年手术量≥201例医院的1.32倍(95%CI 1.30至1.34;p<0.001)。
  • 年手术量11–100例医院成本为年手术量≥201例医院的1.17倍(95%CI 1.17至1.17;p<0.001)。
  • 年手术量101–200例医院成本为年手术量≥201例医院的1.10倍(95%CI 1.10至1.10;p<0.001)。
  • 较小手术量医院患者住院超过2天的OR为1.25至3.44(95%CI 1.10至4.03;p<0.001)。
  • 较小手术量医院患者出院回家OR为0.34至0.78(95%CI 0.29至0.86;p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者提出需进一步研究以识别手术量相关成本差异的关键驱动因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With bundled payments and alternative reimbursement models expanding in scope and scale, reimbursements to hospitals are declining in value. As a result, cost reduction at the hospital level is paramount for the sustainability of profitable inpatient arthroplasty practices. Although multiple prior studies have investigated cost variation in arthroplasty surgery, it is unknown whether contemporary inpatient arthroplasty practices benefit from economies of scale after accounting for hospital characteristics and patient selection factors. Quantifying the independent effects of volume-based cost variation may be important for guiding future value-based health reform. QUESTIONS/PURPOSES: We performed this study to (1) determine whether the cost incurred by hospitals for performing primary inpatient THA and TKA is independently associated with hospital volume and (2) establish whether length of stay and discharge to home are associated with hospital volume. METHODS: The primary data source for this study was the Medicare Provider Analysis and Review Limited Data Set, which includes claims data for 100% of inpatient Medicare hospitalizations. We included patients undergoing primary elective inpatient THA and TKA in 2019. Exclusion criteria included non-Inpatient Prospective Payment System hospitalizations, nonelective admissions, bilateral procedures, and patients with cancer of the pelvis or lower extremities. A total of 500,658 arthroplasties were performed across 2762 hospitals for 492,262 Medicare beneficiaries during the study period; 59% (288,909 of 492,262) of procedures were analyzed after the exclusion criteria were applied. Most exclusions (37% [182,733 of 492,262]) were because of non-Inpatient Prospective Payment System hospitalizations. Among the study group, 87% (251,996 of 288,909) of procedures were in patients who were 65 to 84 years old, 88% (255,415 of 288,909) were performed in patients who were White, and 63% (180,688 of 288,909) were in patients who were women. Elixhauser comorbidities and van Walraven indices were calculated as measures of patient health status. Hospital costs were estimated by multiplying cost-to-charge ratios obtained from the 2019 Impact File by total hospital charges. This methodology enabled us to use the large Medicare Provider Analysis and Review database, which helped decrease the influence of random cost variation through the law of large numbers. Hospital volumes were calculated by stratifying claims by national provider identification number and counting the number of claims per national provider identification number. The data were then grouped into bins of increasing hospital volume to more easily compare larger-volume and smaller-volume centers. The relationship between hospital costs and volume was analyzed using univariable and multivariable generalized linear models. Results are reported as exponential coefficients, which can be interpreted as relative differences in cost. The impact of surgical volume on length of stay and discharge to home was assessed using binary logistic regression, considering the nested structure of the data, and results are reported as odds ratios (OR). RESULTS: Hospital cost and mean length of stay decreased, while rates of discharge to home increased with increasing hospital volume. After controlling for potential confounding variables such as patient demographics, health status, and geographic location, we found that inpatient arthroplasty costs at hospitals with 10 or fewer, 11 to 100, and 101 to 200 procedures annually were 1.32 (95% confidence interval [CI] 1.30 to 1.34; p < 0.001), 1.17 (95% CI 1.17 to 1.17; p < 0.001), and 1.10 (95% CI 1.10 to 1.10; p < 0.001) times greater than those of hospitals with 201 or more inpatient procedures annually. In addition, patients treated at smaller-volume hospitals had increased odds of experiencing a length of stay longer than 2 days (OR 1.25 to 3.44 [95% CI 1.10 to 4.03]; p < 0.001) and decreased odds of being discharged to home (OR 0.34 to 0.78 [95% CI 0.29 to 0.86]; p < 0.001). CONCLUSION: Higher-volume hospitals incur lower costs, shorter lengths of stay, and higher rates of discharge to home than lower-volume hospitals when performing inpatient THA and TKA. These findings suggest that small and medium-sized regional hospitals are disproportionately impacted by declining reimbursement and may necessitate special treatment to remain viable as bundled payment models continue to erode hospital payments. Further research is also warranted to identify the key drivers of this volume-based cost variation, which may facilitate quality improvement initiatives at the hospital and policy levels.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Blackburn CW, Du JY, Moon TJ, et al. High-volume Arthroplasty Centers Are Associated With Lower Hospital Costs When Performing Primary THA and TKA: A Database Study of 288,909 Medicare Claims for Procedures Performed in 2019. Clin Orthop Relat Res. 2022. PMID: 36342359. doi:10.1097/CORR.0000000000002470

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。